Product · Women’s Health

MammoAlert™ & Nidan BioLab™

Breast cancer is the most common cancer among women worldwide. MammoAlert delivers an AI-powered breast cancer risk assessment from a simple finger-prick blood sample in less than 30 minutes — on a low-cost, portable instrument simple enough for any clinical or community setting.

A clinician holding a pink breast cancer awareness ribbon
Built for women’s health

Closing the detection gap for the women who need it most

Breast cancer is the most common cancer among women worldwide, yet routine screening remains out of reach for billions. MammoAlert is designed to expand access far beyond where mammography reaches today.

MammoAlert™

Personalized, AI-enhanced breast cancer risk assessment

MammoAlert integrates five complementary protein biomarkers into a single, explainable AI risk result — designed to expand access to early detection for women everywhere, not replace mammography.

Low Risk Follow-up Recommended High Risk / Diagnostic Follow-up
MammoAlert app welcome and consent screen MammoAlert app result screen showing an AI-interpreted breast cancer risk gauge

How a MammoAlert™ test works

1

Explain consent & collect basic info

2

Personalize based on medical & family history

3

Analyze blood biomarkers in real time

4

Show biomarker test levels

5

Present AI-interpreted risk result

6

Explain next steps in plain language

MammoAlert results are intended to support clinical decision-making and are not a standalone diagnosis.

See MammoAlert™ in action

A closer look at the guided app flow — from onboarding to an explained, actionable result.

MammoAlert app onboarding screen collecting age, region, and demographic information

Guided onboarding

MammoAlert app screen choosing between the MammoAlert device or external lab results as a biomarker data source

Choose your data source

MammoAlert app consent screen for using external certified lab results

External lab results supported

MammoAlert app screen explaining what the biomarker risk result means in plain language

Plain-language explanation

MammoAlert app AI assistant chat screen answering questions about the result

Built-in AI assistant

MammoAlert app recommended next steps screen with a screening reminder

Clear next steps

Five biomarkers, one AI result

Cancer biology cannot be explained by a single biomarker

Each biomarker tells part of the story. Harae Dx’s AI learns the relationships between five complementary biological pathways to generate one explainable cancer risk prediction.

Biomarker 1

A protein whose elevated levels have been linked to more aggressive breast cancer.

Biomarker 2

A protein linked to how likely a tumor is to spread beyond its original site.

Biomarker 3

A well-established blood protein associated with the presence of breast cancer.

Biomarker 4

A protein associated with tumor progression and disease severity.

Biomarker 5

A protein linked to how a tumor sustains its own growth over time.

Illustrative simulation — not a real result

Move the sliders to see how a combined result might look

Low Risk
This is an illustrative demo only. It does not use the MammoAlert AI model, real patient data, or any validated scoring logic — it simply averages the slider positions to show how a multi-biomarker result might be presented. It is not a medical device, not a diagnosis, and not a preview of any actual MammoAlert output.
Nidan BioLab workflow: blood collection, microfluidic disk, instrument analysis, and the final risk report
Nidan BioLab™

A portable lab-in-a-box for point-of-care testing

The Nidan BioLab system pairs a portable instrument with integrated AI analysis and a disposable microfluidic cartridge — designed for deployment in rural clinics, mobile units, and other low-infrastructure settings.

Portable instrument

Integrated AI analysis on-device

Disposable cartridge

Single-use microfluidic disk

Minimal training

Usable by any healthcare worker

<30 minute results

From sample to actionable insight

Inside the cartridge

The microfluidic disk that powers Nidan BioLab

Each single-use disk integrates five parallel assay channels — one per biomarker — on a compact, disposable platform. Precision-molded fluidic pathways route a single blood sample to each reaction site, enabling all five biomarker measurements from one draw, one disk, and one run.

Nidan BioLab microfluidic disk with five integrated biomarker assay channels